bpc-157 ulcerative colitis clinical trial as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Stable gastric pentadecapeptide BPC 157

Baxter M, Colville A (2016) Adverse events in faecal microbiota transplant: a review of the literature

Yes and most clinicians recommend it

Preclinical research suggests that BPC 157 may influence tendon fibroblasts and support collagen-related repair processes

As nicotine and nAChR ligands inhibit macrophage action and neuroinflammation (Godin et al., 2020), we wonder whether nicotine and peripheral nAChRs play a role in reducing nerve regeneration and relieving neuropathic pain

The difference between human-grade and research-grade peptides is not a minor technicality

[DOI] [PMC free article] [PubMed] [Google Scholar] Verderio E.A.M., Johnson T., Griffin M